Group items tagged

Pulmonary Arterial Hypertension (PAH) is a disease that affects the vasculature of the heart, specifically the arteries that transport blood from the heart to the lungs. Common symptoms include heart palpitations or an irregular rhythm, chest pain, coughing, wheezing, shortness of breath, chest discomfort when breathing, and sometimes even heart failure. The cause of pulmonary hypertension is not known, but research has indicated that genetic and hormonal factors may play a role in its development. The growing prevalence of Pulmonary Arterial Hypertension (PAH) is driving the growth of the Pulmonary Arterial Hypertension (PAH) Market. According to the European Respiratory Society, PAH is a rare disease, with an estimated prevalence ranging from 10 to 52 cases per million. The growing geriatric population is again increasing the prevalence of such disease which is also projected to foster the growth of the Pulmonary Arterial Hypertension (PAH) market. According to the United nation, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). By 2050, one in four persons living in Europe and Northern America could be aged 65 or over. North America is projected to gain significant growth over the forecast period and this is attributed to the growing adoption of advanced treatment for treating pulmonary arterial hypertension. Moreover, increasing spending by the government on the healthcare sector is again augmenting the regional market growth. According to the U.S. Centers for Medicare & Medicaid Services, National health spending is projected to grow at an average annual rate of 5.4 percent for 2019-28 and to reach $6.2 trillion by 2028. Reads more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/increasing-global-healthcare-spending.html

The program has reduced systolic and diastolic blood pressure, particularly for those with the highest readings entering the program, and generated high levels of patient satisfaction.

Stroke is a cerebrovascular syndrome that involves the blockage and bursting of blood vessels in the brain. It shows a multifactorial pattern of inheritance. High cholesterol levels, high blood pressure, hypertension and obesity are the key causes of stroke besides inherited genes.

Snoring is the hoarse sound that is produced when air flows past relaxed tissues in throat, giving rise to friction between the tissues that causes vibrations on breathing. Snoring is a common phenomenon found in population, but for some people it could be a serious health condition. Snoring is usually related to a sleep disorder called obstructive sleep apnea (OSA), which is characterized by loud snoring with intervals of silence when breathing stops or nearly stops. The prevalence of sleep apnea in children is around 3%, with the highest frequency between the ages of 2 and 5 years. Snoring can cause several serious health issues especially heart associated ailments including coronary artery disease, atrial fibrillation, stroke systemic hypertension, and anxiety.

The program also provides real-time electronic information to support the provision of appropriate care and offers significant financial incentives that reward practices for becoming recognized as a National Committee for Quality Assurance Patient-Centered Medical Home™. The program has improved the provision of appropriate care and services and reduced utilization and growth in health care spending.

Apollo Hospitals Mumbai offers treatment facilities for Glucose Assessment & Control, Assessment of Complications and Associated Conditions